ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $297,325 | -7.6% | 11,637 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $321,876 | +20.4% | 11,223 | +0.6% | 0.00% | 0.0% |
| Q1 2023 | $267,361 | +44.2% | 11,154 | +2.0% | 0.00% | +100.0% |
| Q4 2022 | $185,424 | +13.8% | 10,933 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $163,000 | -4.1% | 10,973 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $170,000 | -39.9% | 10,817 | +3.2% | 0.00% | -50.0% |
| Q1 2022 | $283,000 | -31.8% | 10,481 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $415,000 | -24.8% | 11,219 | -2.9% | 0.00% | -33.3% |
| Q3 2021 | $552,000 | +38.0% | 11,554 | -2.3% | 0.00% | +200.0% |
| Q2 2021 | $400,000 | -17.5% | 11,829 | +0.8% | 0.00% | -50.0% |
| Q1 2021 | $485,000 | -12.6% | 11,737 | -8.3% | 0.00% | 0.0% |
| Q4 2020 | $555,000 | +35.0% | 12,795 | +33.7% | 0.00% | 0.0% |
| Q3 2020 | $411,000 | +10.2% | 9,569 | +20.0% | 0.00% | 0.0% |
| Q2 2020 | $373,000 | – | 7,975 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
| DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
| One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
| Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
| ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
| EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
| Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
| MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
| Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |